卵巢癌术后静脉血栓栓塞的发生率与危险因素:系统综述与荟萃分析
该研究系统检索并荟萃分析了19项研究,评估上皮性卵巢癌(EOC)术后静脉血栓栓塞(VTE)的发生率及危险因素。术后症状性VTE合并发生率为3%(95%CI 0.03-0.04),症状性及无症状性VTE合并发生率为8%(95%CI 0.07-0.09)。VTE病史、晚期FIGO分期、手术复杂度高、卵巢透明细胞癌、残留病灶>1 cm等显著增加术后VTE风险。
要点
- EOC术后症状性VTE发生率为3%,含无症状性VTE为8%。
- VTE病史、晚期分期、手术复杂、透明细胞癌、残留病灶>1 cm显著增加VTE风险。
- 肥胖、高龄、腹水、ASA>2、吸烟、残留病灶0-1 cm亦为危险因素。
核心结论
- VTE尤其是亚临床VTE是EOC术后常见并发症。
- VTE病史、晚期FIGO分期、手术复杂度高、肥胖、高龄、腹水、较高ASA评分、吸烟史及减瘤不理想与术后VTE发生率增加相关。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Web of Science和Embase数据库。
- 共纳入19项研究。
- 由不同评价者独立进行研究选择、数据提取和质量评估。
- 采用荟萃分析确定EOC女性术后VTE发生率和危险因素,必要时进行敏感性分析验证稳健性。
主要发现
- 术后症状性VTE合并发生率为3%(95% CI,0.03-0.04)。
- 术后症状性及无症状性VTE合并发生率为8%(95% CI,0.07-0.09)。
- VTE病史(OR,2.37)、晚期分期(OR,2.35)、手术复杂度高(OR,2.20)、卵巢透明细胞癌(OR,2.53)和残留病灶>1 cm(OR,2.57)显著增加术后VTE可能性。
- 其他危险因素包括BMI>30(OR,1.58)、年龄每增加10岁(OR,1.22)、ASA评分>2(OR,1.45)、腹水(OR,2.07)、残留病灶直径0-1 cm(OR,2.06)和吸烟史(OR,1.54)。
关键数值与推荐
- 术后症状性VTE合并发生率3%(95% CI,0.03-0.04)。
- 术后症状性及无症状性VTE合并发生率8%(95% CI,0.07-0.09)。
- VTE病史OR 2.37;晚期分期OR 2.35;手术复杂度高OR 2.20;卵巢透明细胞癌OR 2.53;残留病灶>1 cm OR 2.57。
- BMI>30 OR 1.58;年龄每增加10岁OR 1.22;ASA评分>2 OR 1.45;腹水OR 2.07;残留病灶0-1 cm OR 2.06;吸烟史OR 1.54。
临床怎么用
- 对EOC术后患者应警惕VTE,尤其亚临床VTE。
- 对具有VTE病史、晚期分期、手术复杂、透明细胞癌、残留病灶>1 cm等高危因素者应加强VTE风险评估与预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous Thromboembolism (VTE) is a leading cause of morbidity and mortality in patients with ovarian malignancy. There is no meta-analysis available on this topic so far. The aim of our study was to quantitatively synthesize the data from studies with respect to the incidence and risk factors for postoperative VTE among cases with epithelial ovarian cancer (EOC). METHODS: PubMed, Web of Science, and Embase were searched for papers containing the key words "venous thromboembolism", "postoperative", "postoperation", "ovarian neoplasm", "ovary neoplasm", "ovarian cancer", "ovary cancer", and "cancer of ovary". Studies selection, data extraction, quality assessment of eligible studies were performed independently by our different reviewers. Meta-analyses were conducted to determine postoperative VTE incidence and risk factors in women with EOC. Sensitivity analysis were used to verify the robustness of the results of meta-analyses if necessary. RESULTS: In total, 19 studies were included in this meta-analysis. The pooled incidence for postoperative symptomatic VTE was 3% (95% CI, 0.03-0.04) and for postoperative symptomatic as well as asymptomatic VTE was 8% (95% CI, 0.07-0.09). The presence of history of VTE (OR, 2.37), advanced-stages (OR, 2.35), high complexity of surgery (OR, 2.20), clear cell carcinoma of ovary (OR, 2.53) and residual disease>1 cm (OR, 2.57) significantly increase the likelihood of having postoperative VTE. Other risk factors for postoperative VTE in EOC patients were BMI>30 (OR, 1.58), per 10-years increase in age (OR, 1.22), ASA score>2 (OR, 1.45), ascites (OR, 2.07), the diameter of residual disease is between 0 cm to 1 cm (OR, 2.06) and smoking history (OR, 1.54). CONCLUSIONS: This study revealed that VTE, especially subclinical VTE, is a prevalent complication in postoperative patients with EOC. History of VTE, advanced FIGO stages, high complexity of surgery, obesity, older age, ascites, higher ASA score, smoking history and suboptimal debulking are associated with this increased incidence of postoperative VTE among patients with EOC. PROSPERO registration number: CRD42020209662.
引用
- Xu Y, Jia Y, Zhang Q, et al. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis. Gynecol Oncol. 2020. PMID: 33221022. doi:10.1016/j.ygyno.2020.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。